These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31951875)

  • 21. Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.
    Jongen PJ; Lamers KJ; Doesburg WH; Lemmens WA; Hommes OR
    J Neurol Neurosurg Psychiatry; 1997 Oct; 63(4):446-51. PubMed ID: 9343121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis.
    Gasperi C; Salmen A; Antony G; Bayas A; Heesen C; Kümpfel T; Linker RA; Paul F; Stangel M; Tackenberg B; Bergh FT; Warnke C; Weber F; Wiendl H; Wildemann B; Zettl UK; Ziemann U; Zipp F; Tumani H; Gold R; Hemmer B;
    JAMA Neurol; 2019 Jul; 76(7):841-849. PubMed ID: 31034002
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis.
    Lunemann JD; Hegen H; Villar LM; Rejdak K; Sao-Aviles A; Carbonell-Mirabent P; Sastre-Garriga J; Mongay-Ochoa N; Berek K; Martínez-Yélamos S; Pérez-Miralles F; Abdelhak A; Bachhuber F; Tumani H; Lycke JN; Rosenstein I; Alvarez-Lafuente R; Castillo-Trivino T; Otaegui D; Llufriu S; Blanco Y; Sánchez López AJ; Garcia Merino JA; Fissolo N; Gutierrez L; Villacieros-Álvarez J; Monreal E; Valls-Carbó A; Wiendl H; Montalban X; Comabella M
    Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200270. PubMed ID: 38912898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Axonal damage markers in the cerebrospinal fluid of patients with clinically isolated syndrome improve predicting conversion to definite multiple sclerosis.
    Brettschneider J; Petzold A; Junker A; Tumani H
    Mult Scler; 2006 Apr; 12(2):143-8. PubMed ID: 16629417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course.
    Khademi M; Kockum I; Andersson ML; Iacobaeus E; Brundin L; Sellebjerg F; Hillert J; Piehl F; Olsson T
    Mult Scler; 2011 Mar; 17(3):335-43. PubMed ID: 21135023
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CSF levels of HoxB3 and YKL-40 may predict conversion from clinically isolated syndrome to relapsing remitting multiple sclerosis.
    Tamam Y; Gunes B; Akbayir E; Kizilay T; Karaaslan Z; Koral G; Duzel B; Kucukali CI; Gunduz T; Kurtuncu M; Yilmaz V; Tuzun E; Turkoglu R
    Mult Scler Relat Disord; 2021 Feb; 48():102697. PubMed ID: 33352356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients.
    Sejbaek T; Nielsen HH; Penner N; Plavina T; Mendoza JP; Martin NA; Elkjaer ML; Ravnborg MH; Illes Z
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1324-1330. PubMed ID: 31611264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis.
    Magliozzi R; Hametner S; Facchiano F; Marastoni D; Rossi S; Castellaro M; Poli A; Lattanzi F; Visconti A; Nicholas R; Reynolds R; Monaco S; Lassmann H; Calabrese M
    Ann Clin Transl Neurol; 2019 Nov; 6(11):2150-2163. PubMed ID: 31675181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis.
    Fialová L; Bartos A; Svarcová J; Zimova D; Kotoucova J; Malbohan I
    J Neuroimmunol; 2013 Sep; 262(1-2):113-20. PubMed ID: 23870535
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrathecal B-cell accumulation and axonal damage distinguish MRI-based benign from aggressive onset in MS.
    Engel S; Friedrich M; Muthuraman M; Steffen F; Poplawski A; Groppa S; Bittner S; Zipp F; Luessi F
    Neurol Neuroimmunol Neuroinflamm; 2019 Sep; 6(5):. PubMed ID: 31454774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome.
    Matute-Blanch C; Villar LM; Álvarez-Cermeño JC; Rejdak K; Evdoshenko E; Makshakov G; Nazarov V; Lapin S; Midaglia L; Vidal-Jordana A; Drulovic J; García-Merino A; Sánchez-López AJ; Havrdova E; Saiz A; Llufriu S; Alvarez-Lafuente R; Schroeder I; Zettl UK; Galimberti D; Ramió-Torrentà L; Robles R; Quintana E; Hegen H; Deisenhammer F; Río J; Tintoré M; Sánchez A; Montalban X; Comabella M
    Brain; 2018 Apr; 141(4):1085-1093. PubMed ID: 29452342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid complement activation in patients with pneumococcal and meningococcal meningitis.
    Mook-Kanamori BB; Brouwer MC; Geldhoff M; Ende Av; van de Beek D
    J Infect; 2014 Jun; 68(6):542-7. PubMed ID: 24412248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis.
    Avsar T; Korkmaz D; Tütüncü M; Demirci NO; Saip S; Kamasak M; Siva A; Turanli ET
    Mult Scler; 2012 Aug; 18(8):1081-91. PubMed ID: 22252467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spinal Fluid Myeloid Microvesicles Predict Disease Course in Multiple Sclerosis.
    Gelibter S; Pisa M; Croese T; Finardi A; Mandelli A; Sangalli F; Colombo B; Martinelli V; Comi G; Filippi M; Furlan R
    Ann Neurol; 2021 Aug; 90(2):253-265. PubMed ID: 34216397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
    Voortman MM; Stojakovic T; Pirpamer L; Jehna M; Langkammer C; Scharnagl H; Reindl M; Ropele S; Seifert-Held T; Archelos JJ; Fuchs S; Enzinger C; Fazekas F; Khalil M
    Mult Scler; 2017 Oct; 23(11):1496-1505. PubMed ID: 27899552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholesterol levels in plasma and cerebrospinal fluid in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis.
    Evangelopoulos ME; Koutsis G; Boufidou F; Markianos M
    Neurobiol Dis; 2022 Nov; 174():105889. PubMed ID: 36209949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.
    Teunissen CE; Sombekke M; van Winsen L; Killestein J; Barkhof F; Polman CH; Dijkstra CD; Blankenstein MA; Pratico D
    Mult Scler; 2012 Aug; 18(8):1092-8. PubMed ID: 22695538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis.
    Martínez MA; Olsson B; Bau L; Matas E; Cobo Calvo Á; Andreasson U; Blennow K; Romero-Pinel L; Martínez-Yélamos S; Zetterberg H
    Mult Scler; 2015 Apr; 21(5):550-61. PubMed ID: 25732842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cisterno-lumbar gradient of complement fractions in geriatric patients with suspected normal pressure hydrocephalus.
    Seele J; Kirschfink M; Djukic M; Lange P; Gossner J; Bunkowski S; Wiltfang J; Nau R
    Clin Chim Acta; 2018 Nov; 486():1-7. PubMed ID: 30003878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Osteopontin concentrations are increased in cerebrospinal fluid during attacks of multiple sclerosis.
    Börnsen L; Khademi M; Olsson T; Sørensen PS; Sellebjerg F
    Mult Scler; 2011 Jan; 17(1):32-42. PubMed ID: 20921238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.